Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | $2.8B | $3.1B | $3.6B | $3.9B | |
| Revenue Growth (YoY) | 6.25% | 45.17% | 8% | 15.7% | 8.91% | |
| Cost of Revenues | $1.4B | $1.9B | $2.1B | $2.4B | $2.7B | |
| Gross Profit | $583M | $945.6M | $989.9M | $1.1B | $1.2B | |
| Gross Profit Margin | 29.71% | 33.2% | 32.18% | 32.12% | 30.57% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $488.5M | $639.7M | $739.7M | $739.2M | $842.5M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $419.2M | $554.8M | $634.1M | $739.2M | $842.5M | |
| Operating Income | $163.8M | $390.8M | $355.7M | $403.9M | $342.7M | |
| Net Interest Expenses | $1.7M | $3.5M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $153.1M | $366.7M | $347.5M | $401.1M | $338.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29.7M | $87.9M | $86M | $100M | $85.1M | |
| Net Income to Company | $123.4M | $278.8M | $261.5M | $301.1M | $253.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $123.4M | $278.8M | $261.5M | $301.1M | $253.6M | |
| Basic EPS (Cont. Ops) | $2.21 | $4.98 | $4.71 | $5.43 | $4.61 | |
| Diluted EPS (Cont. Ops) | $2.20 | $4.95 | $4.69 | $5.41 | $4.60 | |
| Weighted Average Basic Share | $55.8M | $56M | $55.5M | $55.5M | $55.1M | |
| Weighted Average Diluted Share | $56.1M | $56.3M | $55.7M | $55.6M | $55.2M | |
| EBITDA | $233.1M | $475.6M | $461.4M | $534.6M | $510.2M | |
| EBIT | $163.8M | $390.8M | $355.7M | $403.9M | $342.7M | |
| Revenue (Reported) | $2B | $2.8B | $3.1B | $3.6B | $3.9B | |
| Operating Income (Reported) | $163.8M | $390.8M | $355.7M | $403.9M | $342.7M | |
| Operating Income (Adjusted) | $163.8M | $390.8M | $355.7M | $403.9M | $342.7M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $607.6M | $645M | $736.4M | $843.7M | $1B | |
| Revenue Growth (YoY) | 27.49% | 6.15% | 14.17% | 14.57% | 23.06% | |
| Cost of Revenues | $428.4M | $464.8M | $547.2M | $628.9M | $735.8M | |
| Gross Profit | $179.2M | $180.2M | $189.2M | $214.8M | $302.5M | |
| Gross Profit Margin | 29.5% | 27.94% | 25.7% | 25.45% | 29.14% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $159.9M | $186.9M | $206.7M | $215.4M | $259.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $136.8M | $159.3M | $173.1M | $215.4M | $259.2M | |
| Operating Income | $42.4M | $20.9M | $16.1M | -$606K | $43.3M | |
| Net Interest Expenses | $924K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $31.8M | $21.4M | $19.6M | $2.2M | $49.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.6M | $5.3M | $5M | $515K | $12.6M | |
| Net Income to Company | $24.2M | $16.1M | $14.6M | $1.7M | $36.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $24.2M | $16.1M | $14.6M | $1.7M | $36.5M | |
| Basic EPS (Cont. Ops) | $0.43 | $0.29 | $0.26 | $0.03 | $0.66 | |
| Diluted EPS (Cont. Ops) | $0.43 | $0.29 | $0.26 | $0.03 | $0.66 | |
| Weighted Average Basic Share | $56M | $55.5M | $55.5M | $55M | $55.2M | |
| Weighted Average Diluted Share | $56.3M | $55.7M | $55.6M | $55.1M | $55.6M | |
| EBITDA | $65.6M | $48.5M | $49.7M | $42.7M | $92.2M | |
| EBIT | $42.4M | $20.9M | $16.1M | -$606K | $43.3M | |
| Revenue (Reported) | $607.6M | $645M | $736.4M | $843.7M | $1B | |
| Operating Income (Reported) | $42.4M | $20.9M | $16.1M | -$606K | $43.3M | |
| Operating Income (Adjusted) | $42.4M | $20.9M | $16.1M | -$606K | $43.3M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.9B | $3.3B | $3.8B | $4.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8B | $2.1B | $2.3B | $2.6B | $3B | |
| Gross Profit | $893.5M | $878.5M | $1.1B | $1.2B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $612.6M | $733.1M | $831.7M | $840.4M | $995.1M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $531.5M | $571.6M | $709.1M | $840.4M | $995.1M | |
| Operating Income | $361.9M | $306.9M | $342.9M | $345.5M | $393.3M | |
| Net Interest Expenses | $3.7M | $742K | -- | -- | -- | |
| EBT. Incl. Unusual Items | $348.5M | $306.7M | $356.5M | $360.5M | $414.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $86M | $76.3M | $86.2M | $92.1M | $106.4M | |
| Net Income to Company | $262.6M | $230.4M | $270.2M | $268.4M | $307.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $262.6M | $230.4M | $270.2M | $268.4M | $307.9M | |
| Basic EPS (Cont. Ops) | $4.69 | $4.13 | $4.86 | $4.86 | $5.59 | |
| Diluted EPS (Cont. Ops) | $4.67 | $4.11 | $4.84 | $4.85 | $5.57 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $442.9M | $468.4M | $465.5M | $504.5M | $581.9M | |
| EBIT | $361.9M | $306.9M | $342.9M | $345.5M | $393.3M | |
| Revenue (Reported) | $2.7B | $2.9B | $3.3B | $3.8B | $4.4B | |
| Operating Income (Reported) | $361.9M | $306.9M | $342.9M | $345.5M | $393.3M | |
| Operating Income (Adjusted) | $361.9M | $306.9M | $342.9M | $345.5M | $393.3M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | $2B | $2.2B | $2.5B | $3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.3B | $1.4B | $1.6B | $1.8B | $2.2B | |
| Gross Profit | $571M | $566.4M | $628.6M | $671.4M | $874.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $441.2M | $523.8M | $605.1M | $594.4M | $728.1M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $378.6M | $447.1M | $511.4M | $594.4M | $728.1M | |
| Operating Income | $192.3M | $119.3M | $117.1M | $77.1M | $146.5M | |
| Net Interest Expenses | $3M | $237K | -- | -- | -- | |
| EBT. Incl. Unusual Items | $179.6M | $119.6M | $128.6M | $87.9M | $163.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $41M | $29.4M | $29.6M | $21.8M | $43.1M | |
| Net Income to Company | $138.6M | $90.2M | $98.9M | $66.2M | $120.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $138.6M | $90.2M | $98.9M | $66.2M | $120.4M | |
| Basic EPS (Cont. Ops) | $2.48 | $1.62 | $1.78 | $1.20 | $2.19 | |
| Diluted EPS (Cont. Ops) | $2.46 | $1.62 | $1.77 | $1.20 | $2.17 | |
| Weighted Average Basic Share | $168M | $166.7M | $166.8M | $165.2M | $165.3M | |
| Weighted Average Diluted Share | $168.9M | $167.2M | $167.2M | $165.4M | $166.2M | |
| EBITDA | $254.9M | $196M | $210.8M | $199M | $289.6M | |
| EBIT | $192.3M | $119.3M | $117.1M | $77.1M | $146.5M | |
| Revenue (Reported) | $1.9B | $2B | $2.2B | $2.5B | $3B | |
| Operating Income (Reported) | $192.3M | $119.3M | $117.1M | $77.1M | $146.5M | |
| Operating Income (Adjusted) | $192.3M | $119.3M | $117.1M | $77.1M | $146.5M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $409.7M | $342.1M | $399.2M | $460.1M | $528.8M | |
| Short Term Investments | $140.9M | $277.1M | $66.8M | $280.3M | $197.1M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $281.3M | $455.1M | $527.7M | $584.6M | $659.5M | |
| Prepaid Expenses | $25.4M | $37.7M | $25.9M | $30.5M | $37.7M | |
| Other Current Assets | $39.1M | $96.2M | $104.7M | $123.5M | $120.7M | |
| Total Current Assets | $755.4M | $904.7M | $1.1B | $1.2B | $1.4B | |
| Property Plant And Equipment | $1.5B | $1.9B | $2.2B | $2.6B | $3B | |
| Long-Term Investments | -- | $37.7M | -- | $7.8M | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $18.1M | $9.1M | $13.9M | $17M | $19.9M | |
| Total Assets | $2.6B | $3.3B | $3.7B | $4.3B | $4.9B | |
| Accounts Payable | $138.6M | $196.5M | $221.1M | $256.3M | $260.3M | |
| Accrued Expenses | $151.9M | $198.8M | $161.7M | $176.9M | $169.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $143.1M | $163.5M | $199.8M | $241M | $274.9M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $435.7M | $586.9M | $602.6M | $715.9M | $756.4M | |
| Long-Term Debt | $967.3M | $1.1B | $1.3B | $1.5B | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7B | $2.1B | $2.4B | $2.7B | $3.1B | |
| Common Stock | $559K | $556K | $555K | $551K | $549K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $881.9M | $1.1B | $1.4B | $1.6B | $1.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $881.9M | $1.1B | $1.4B | $1.6B | $1.8B | |
| Total Liabilities and Equity | $2.6B | $3.3B | $3.7B | $4.3B | $4.9B | |
| Cash and Short Terms | $409.7M | $342.1M | $399.2M | $460.1M | $528.8M | |
| Total Debt | $967.3M | $1.1B | $1.3B | $1.5B | $1.7B | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $311.3M | $117M | $162.9M | $216.6M | $524.5M | |
| Short Term Investments | $224.6M | $72.7M | -- | $46.9M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $521.1M | $701.6M | $763.3M | $817.8M | $1.1B | |
| Prepaid Expenses | $26.5M | $27.6M | $31.1M | $42M | $38.2M | |
| Other Current Assets | $77.5M | $113.1M | $109.7M | $157.4M | -- | |
| Total Current Assets | $933.9M | $957M | $1.1B | $1.2B | $1.8B | |
| Property Plant And Equipment | $1.9B | $2.2B | $2.6B | $3B | $3B | |
| Long-Term Investments | -- | -- | -- | -- | $11.3M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $9.6M | $13.8M | $16.1M | $20.4M | -- | |
| Total Assets | $2.8B | $3.2B | $3.7B | $4.2B | $4.8B | |
| Accounts Payable | $253.8M | $279.8M | $349.3M | $352.2M | $519.7M | |
| Accrued Expenses | $196.2M | $166.4M | $177.6M | $172.1M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $162.8M | $193.6M | $231.2M | $351.1M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $613.6M | $639.9M | $758.2M | $875.4M | $1.1B | |
| Long-Term Debt | $1.1B | $1.3B | $1.5B | $1.6B | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.8B | $2B | $2.3B | $2.6B | $2.8B | |
| Common Stock | $560K | $555K | $551K | $549K | $550K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1B | $1.2B | $1.4B | $1.6B | $2B | |
| Total Liabilities and Equity | $2.8B | $3.2B | $3.7B | $4.2B | $4.8B | |
| Cash and Short Terms | $311.3M | $117M | $162.9M | $216.6M | $524.5M | |
| Total Debt | $1.1B | $1.3B | $1.5B | $1.6B | $1.7B | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $123.4M | $278.8M | $261.5M | $301.1M | $253.6M | |
| Depreciation & Amoritzation | $69.3M | $84.8M | $105.6M | $130.7M | $167.4M | |
| Stock-Based Compensation | $9.6M | $25.8M | $23.6M | $17.9M | $15.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | $42.8M | -$173.8M | -$72.6M | -$56.9M | -$74.9M | |
| Cash From Operations | $363.9M | $327.9M | $314.7M | $499.6M | $430.6M | |
| Capital Expenditures | $200.2M | $288.2M | $252M | $335.1M | $324M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$286.9M | -$465.6M | -$3.9M | -$556.3M | -$232.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $50M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$50M | -- | -- | -- | -- | |
| Repurchase of Common Stock | $12.7M | $60M | $40M | $80.5M | $40.2M | |
| Other Financing Activities | -$2M | -- | -$248K | -- | -- | |
| Cash From Financing | -$10.8M | -$66.1M | -$43.4M | -$95.9M | -$45.7M | |
| Beginning Cash (CF) | $268.8M | $65M | $332.3M | $179.7M | $331.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $66.3M | -$203.8M | $267.4M | -$152.6M | $152M | |
| Ending Cash (CF) | $335.1M | -$138.8M | $599.7M | $27.2M | $483.7M | |
| Levered Free Cash Flow | $163.7M | $39.7M | $62.7M | $164.6M | $106.7M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $24.2M | $16.1M | $14.6M | $1.7M | $36.5M | |
| Depreciation & Amoritzation | $23.1M | $27.6M | $33.6M | $43.3M | $48.9M | |
| Stock-Based Compensation | $6.8M | $6M | $3.8M | $6.6M | $7.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$173.8M | -$132.4M | -$219.7M | -$178M | -$312.7M | |
| Cash From Operations | -$24.1M | -$91.1M | -$77.4M | -$30.6M | -$80.1M | |
| Capital Expenditures | $78.6M | $63.9M | $115.5M | $80.4M | $53M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.1M | -$19.3M | -$13.7M | -$8.6M | -$130.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $80.5M | -- | -- | |
| Other Financing Activities | -- | -$248K | -- | -- | -- | |
| Cash From Financing | -$170K | -$447K | -$80.6M | -$111K | -$1.2M | |
| Beginning Cash (CF) | $86.8M | $44.2M | $162.9M | $169.7M | $351M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$39.4M | -$110.9M | -$171.6M | -$39.3M | -$211.8M | |
| Ending Cash (CF) | $47.3M | -$66.6M | -$8.7M | $130.4M | $139.2M | |
| Levered Free Cash Flow | -$102.7M | -$155M | -$192.9M | -$111M | -$133.2M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $262.6M | $230.4M | $270.2M | $268.4M | $307.9M | |
| Depreciation & Amoritzation | $81M | $98.9M | $122.6M | $159M | $188.6M | |
| Stock-Based Compensation | $25.1M | $24.8M | $18.8M | $15.8M | $30.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$90.9M | -$180.5M | -$61.8M | -$54.5M | -$294.4M | |
| Cash From Operations | $369.1M | $158.3M | $451.5M | $474.8M | $509.1M | |
| Capital Expenditures | $264.1M | $248.5M | $310.3M | $375M | $186.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$395.4M | -$96.7M | -$237.6M | -$421.9M | -$323.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $100M | $80.5M | $40.2M | -$13K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$3.9M | -$104.1M | -$95.3M | -$46.1M | -$3.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$30.3M | -$42.5M | $118.7M | $6.8M | $181.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $104.9M | -$90.3M | $141.3M | $99.9M | $323M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $138.6M | $90.2M | $98.9M | $66.2M | $120.4M | |
| Depreciation & Amoritzation | $62.6M | $76.7M | $93.7M | $121.9M | $143.1M | |
| Stock-Based Compensation | $19.2M | $18.1M | $13.4M | $11.3M | $26.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$239.8M | -$246.5M | -$235.6M | -$233.2M | -$452.8M | |
| Cash From Operations | $124.7M | -$45M | $91.9M | $67.1M | $145.5M | |
| Capital Expenditures | $213.2M | $173.6M | $231.9M | $271.9M | $134M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$300.3M | $68.5M | -$165.1M | -$30.7M | -$121.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $40M | $80.5M | $40.2M | -- | |
| Other Financing Activities | -- | -$248K | -- | -- | -$1.3M | |
| Cash From Financing | -$6.3M | -$44.3M | -$96.2M | -$46.5M | -$4.6M | |
| Beginning Cash (CF) | $297.1M | $319.8M | $832.8M | $475M | $1.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$182M | -$20.7M | -$169.4M | -$10M | $19.3M | |
| Ending Cash (CF) | $115.1M | $299.1M | $663.4M | $465M | $1.4B | |
| Levered Free Cash Flow | -$88.6M | -$218.6M | -$140M | -$204.7M | $11.6M | |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.